Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice

Fuminori Abe, Akira Matsuda, Mark Schneider, James E Talmadge

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The effect of bestatin on hematopoietic parameters and bone marrow progenitor activity (colony-forming unit - granulocyte/macrophage: CFU-GM) was examined in normal and myelosuppressed C57BL/6 mice. CFU-GM frequency and absolute number were determined with a limiting dilution analysis of bone marrow cells in soft agar using recombinant murine colony-stimulating factor - granulocyte/macrophage. We report that bestatin increased splenic, bone marrow, and peripheral blood cellularity and the number of CFU-GM over a dose range from 2.5 mg/kg through 100 mg/kg following i.p., i.v., or oral administration. The greatest myeloid stimulation was observed following multiple injections of bestatin. Bestatin also increased the recovery from cyclophosphamide-induced myelodepression as measured by these parameters. The hematopoietic properties of bestatin following oral administration is of potential importance for clinical application.

Original languageEnglish (US)
Pages (from-to)75-80
Number of pages6
JournalCancer Immunology Immunotherapy
Volume32
Issue number2
DOIs
StatePublished - Mar 1 1990

Fingerprint

Granulocyte-Macrophage Progenitor Cells
Cyclophosphamide
Stem Cells
Oral Administration
Bone Marrow
Granulocyte-Macrophage Colony-Stimulating Factor
Inbred C57BL Mouse
Bone Marrow Cells
Agar
ubenimex
Injections

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this

Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice. / Abe, Fuminori; Matsuda, Akira; Schneider, Mark; Talmadge, James E.

In: Cancer Immunology Immunotherapy, Vol. 32, No. 2, 01.03.1990, p. 75-80.

Research output: Contribution to journalArticle

@article{35b5aa3a329740a59dcc10f93d0eed89,
title = "Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice",
abstract = "The effect of bestatin on hematopoietic parameters and bone marrow progenitor activity (colony-forming unit - granulocyte/macrophage: CFU-GM) was examined in normal and myelosuppressed C57BL/6 mice. CFU-GM frequency and absolute number were determined with a limiting dilution analysis of bone marrow cells in soft agar using recombinant murine colony-stimulating factor - granulocyte/macrophage. We report that bestatin increased splenic, bone marrow, and peripheral blood cellularity and the number of CFU-GM over a dose range from 2.5 mg/kg through 100 mg/kg following i.p., i.v., or oral administration. The greatest myeloid stimulation was observed following multiple injections of bestatin. Bestatin also increased the recovery from cyclophosphamide-induced myelodepression as measured by these parameters. The hematopoietic properties of bestatin following oral administration is of potential importance for clinical application.",
author = "Fuminori Abe and Akira Matsuda and Mark Schneider and Talmadge, {James E}",
year = "1990",
month = "3",
day = "1",
doi = "10.1007/BF01754202",
language = "English (US)",
volume = "32",
pages = "75--80",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "2",

}

TY - JOUR

T1 - Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice

AU - Abe, Fuminori

AU - Matsuda, Akira

AU - Schneider, Mark

AU - Talmadge, James E

PY - 1990/3/1

Y1 - 1990/3/1

N2 - The effect of bestatin on hematopoietic parameters and bone marrow progenitor activity (colony-forming unit - granulocyte/macrophage: CFU-GM) was examined in normal and myelosuppressed C57BL/6 mice. CFU-GM frequency and absolute number were determined with a limiting dilution analysis of bone marrow cells in soft agar using recombinant murine colony-stimulating factor - granulocyte/macrophage. We report that bestatin increased splenic, bone marrow, and peripheral blood cellularity and the number of CFU-GM over a dose range from 2.5 mg/kg through 100 mg/kg following i.p., i.v., or oral administration. The greatest myeloid stimulation was observed following multiple injections of bestatin. Bestatin also increased the recovery from cyclophosphamide-induced myelodepression as measured by these parameters. The hematopoietic properties of bestatin following oral administration is of potential importance for clinical application.

AB - The effect of bestatin on hematopoietic parameters and bone marrow progenitor activity (colony-forming unit - granulocyte/macrophage: CFU-GM) was examined in normal and myelosuppressed C57BL/6 mice. CFU-GM frequency and absolute number were determined with a limiting dilution analysis of bone marrow cells in soft agar using recombinant murine colony-stimulating factor - granulocyte/macrophage. We report that bestatin increased splenic, bone marrow, and peripheral blood cellularity and the number of CFU-GM over a dose range from 2.5 mg/kg through 100 mg/kg following i.p., i.v., or oral administration. The greatest myeloid stimulation was observed following multiple injections of bestatin. Bestatin also increased the recovery from cyclophosphamide-induced myelodepression as measured by these parameters. The hematopoietic properties of bestatin following oral administration is of potential importance for clinical application.

UR - http://www.scopus.com/inward/record.url?scp=0025651812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025651812&partnerID=8YFLogxK

U2 - 10.1007/BF01754202

DO - 10.1007/BF01754202

M3 - Article

VL - 32

SP - 75

EP - 80

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 2

ER -